Use your antibodies-online credentials, if available.
CLEC14A encodes a member of the C-type lectin/C-type lectin-like domain (CTL/CTLD) superfamily. 再加上，我们可以发CLEC14A 抗体 (49) 和 CLEC14A 试剂盒 (3)和数多这个蛋白质的别的产品。
Showing 5 out of 7 products:
These findings identify novel protein interactions involving CLEC14A, CD93 (显示 CD93 蛋白) and CD248 (显示 CD248 蛋白) with MMRN2 (显示 MMRN2 蛋白) as targetable components of vessel formation
The CLEC14A-MMRN2 (显示 MMRN2 蛋白) interaction is involved in sprouting angiogenesis. Disrupting this interaction with monoclonal antibodies directed against CLEC14A show anti-angiogenic and anti-tumor effects.
CLEC14A is a matrix component which binds to MMRN2 (显示 MMRN2 蛋白) in the process of endothelial cells transformation in tumor angiogenesis.
clec14a-CTLD may be a key domain in angiogenesis
In this study, they identify and characterize a novel tumor endothelial marker, CLEC14A, which has properties that suggest it is a candidate for tumor vascular targeting and anti-angiogenic approaches.
CLEC14A acts in vascular homeostasis by fine-tuning VEGFR-2 (显示 KDR 蛋白) and VEGFR-3 (显示 FLT4 蛋白) signaling in endothelial cells
These findings demonstrate that Clec14a is a novel endothelial cells specific protein that appears to play a role in cell-cell adhesion and angiogenesis.
This gene encodes a member of the C-type lectin/C-type lectin-like domain (CTL/CTLD) superfamily. Members of this family share a common protein fold and have diverse functions, such as cell adhesion, cell-cell signalling, glycoprotein turnover, and roles in inflammation and immune response. This family member plays a role in cell-cell adhesion and angiogenesis. It functions in filopodia formation, cell migration and tube formation. Due to its presence at higher levels in tumor endothelium than in normal tissue endothelium, it is considered to be a candidate for tumor vascular targeting.
C-type lectin domain family 14 member A
, ClECT and EGF-like domain containing protein
, epidermal growth factor receptor 5